GSK3B and Alzheimer disease: Increased expression and activity of GSK3β has been noted in AD, PD, and ALS post-mortem tissue while decreased expression and activity was reported in Huntington’s disease (HD) patient brains (Pajak et al., 2009; Lim et al., 2014; Credle et al., 2015; Nicolia et al., 2017).